The overall survival of lung cancer patients showed that low RRM2 expression had a better prognosis (p=0.000015) (Figure 7G), and disease-free survival also suggested that patients with low RRM2 expression had a better prognosis (p=0.019) (Figure 7H). This evidence concerns the gene RRM2 and lung cancer.